Cost-effectiveness of Screening Program for Chronic Q Fever, the Netherlands
Pieter T. de Boer
, Marit M.A. de Lange, Cornelia C.H. Wielders, Frederika Dijkstra, Sonja E. van Roeden, Chantal P. Bleeker-Rovers, Jan Jelrik Oosterheert, Peter M. Schneeberger, and Wim van der Hoek
Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (P.T. de Boer, M.M.A. de Lange, C.C.H. Wielders, F. Dijkstra, W. van der Hoek); University Medical Centre Utrecht, Utrecht, the Netherlands (S.E. van Roeden, J.J. Oosterheert); Radboud university medical center, Nijmegen, the Netherlands (C.P. Bleeker-Rovers); Jeroen Bosch Hospital, ’s-Hertogenbosch, the Netherlands (P.M. Schneeberger)
Main Article
Figure 1
Figure 1. Schematic overview of the health-economic model in a study of the cost-effectiveness of screening for CQF, the Netherlands, 2017. Black square represents model input; green squares are model processes; blue squares are model parameters; and red squares are model outputs. Individual decision trees for screening and clinical outcomes are shown in Appendix
Main Article
Page created: January 17, 2020
Page updated: January 17, 2020
Page reviewed: January 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.